Dorinda Mullen1, Sarah Mullins1, Aoife Doyle1, Rachel K Crowley2,3, Stephen Skehan4,3, Enda W McDermott5,3, Ruth S Prichard5,3, David Gibbons1,3. 1. Department of Pathology, St. Vincent's University Hospital, Dublin 4, Ireland. 2. Department of Endocrinology, St. Vincent's University Hospital, Dublin 4, Ireland. 3. School of Medicine and Medical Sciences, University College Dublin, Dublin 4, Ireland. 4. Department of Radiology, St. Vincent's University Hospital, Dublin 4, Ireland. 5. Department of Surgery, St. Vincent's University Hospital, Dublin 4, Ireland.
Abstract
OBJECTIVE: Thyroid nodules are common within the general population. Cytological analysis of fine needle aspirates (FNAs) of these lesions allows for identification of those that require further surgery. A numerical classification system is in place to streamline reporting. The 3a category is used for lesions that are neither benign nor malignant but show atypia of undetermined significance. We reviewed our use and clinical outcomes of Thy3a over a 4-year period. METHODS: All thyroid FNAs performed at this institute from January 2012 to December 2015 were identified from our laboratory information system using SNOMED codes. Cytology was correlated with histology. RESULTS: Of the 1,259 FNAs reported at this institute, Thy3a constituted only 1.2% (n = 16) of all cases, with a malignancy rate of 7%. Five Thy3a cases had a repeat FNA that was reported as Thy2 (benign), 1 as Thy1c (cyst), 1 as Thy3f (follicular lesion), and 1 as Thy5 (malignant). Six cases without repeat FNA were follicular adenomas at resection. Two cases were lost to follow-up. Within all thyroid cytology categories in this 4-year period, we had a false-positive rate of 1.9% and a false-negative rate of 0.3%. CONCLUSIONS: The Thy3a subclassification has varied diagnostic criteria and lacks reproducibility. Despite the rare use of the Thy3a category at our centre, our diagnostic accuracy remained high. At this time, further Thy3a cohort studies are required to assess the real benefits of this category.
OBJECTIVE: Thyroid nodules are common within the general population. Cytological analysis of fine needle aspirates (FNAs) of these lesions allows for identification of those that require further surgery. A numerical classification system is in place to streamline reporting. The 3a category is used for lesions that are neither benign nor malignant but show atypia of undetermined significance. We reviewed our use and clinical outcomes of Thy3a over a 4-year period. METHODS: All thyroid FNAs performed at this institute from January 2012 to December 2015 were identified from our laboratory information system using SNOMED codes. Cytology was correlated with histology. RESULTS: Of the 1,259 FNAs reported at this institute, Thy3a constituted only 1.2% (n = 16) of all cases, with a malignancy rate of 7%. Five Thy3a cases had a repeat FNA that was reported as Thy2 (benign), 1 as Thy1c (cyst), 1 as Thy3f (follicular lesion), and 1 as Thy5 (malignant). Six cases without repeat FNA were follicular adenomas at resection. Two cases were lost to follow-up. Within all thyroid cytology categories in this 4-year period, we had a false-positive rate of 1.9% and a false-negative rate of 0.3%. CONCLUSIONS: The Thy3a subclassification has varied diagnostic criteria and lacks reproducibility. Despite the rare use of the Thy3a category at our centre, our diagnostic accuracy remained high. At this time, further Thy3a cohort studies are required to assess the real benefits of this category.
Entities:
Keywords:
Atypia of uncertain significance; Cytology; Follicular neoplasm; Thyroid
Authors: Gabrijela Kocjan; Ashish Chandra; Paul A Cross; Thomas Giles; Sarah J Johnson; Timothy J Stephenson; Michael Roughton; David N Poller Journal: Am J Clin Pathol Date: 2011-06 Impact factor: 2.493
Authors: Salem I Noureldine; Alireza Najafian; Patricia Aragon Han; Matthew T Olson; Dane J Genther; Eric B Schneider; Jason D Prescott; Nishant Agrawal; Aarti Mathur; Martha A Zeiger; Ralph P Tufano Journal: JAMA Otolaryngol Head Neck Surg Date: 2016-07-01 Impact factor: 6.223
Authors: N Paul Ohori; Rashi Singhal; Marina N Nikiforova; Linwah Yip; Karen E Schoedel; Christopher Coyne; Kelly L McCoy; Shane O LeBeau; Steven P Hodak; Sally E Carty; Yuri E Nikiforov Journal: Cancer Cytopathol Date: 2012-08-07 Impact factor: 5.284
Authors: Yuri E Nikiforov; David L Steward; Toni M Robinson-Smith; Bryan R Haugen; Joshua P Klopper; Zhaowen Zhu; James A Fagin; Mercedes Falciglia; Katherine Weber; Marina N Nikiforova Journal: J Clin Endocrinol Metab Date: 2009-03-24 Impact factor: 5.958